Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Palliative surgical management of patients with unresectable pancreatic adenocarcinoma: trends and lessons learned from a large, single institution experience.

Kneuertz PJ, Cunningham SC, Cameron JL, Torrez S, Tapazoglou N, Herman JM, Makary MA, Eckhauser F, Wang J, Hirose K, Edil BH, Choti MA, Schulick RD, Wolfgang CL, Pawlik TM.

J Gastrointest Surg. 2011 Nov;15(11):1917-27. doi: 10.1007/s11605-011-1665-9. Epub 2011 Sep 13.

2.

Patients with laparoscopically staged unresectable pancreatic adenocarcinoma do not require subsequent surgical biliary or gastric bypass.

Espat NJ, Brennan MF, Conlon KC.

J Am Coll Surg. 1999 Jun;188(6):649-55; discussion 655-7.

PMID:
10359358
3.

Tumour cryoablation combined with palliative bypass surgery in the treatment of unresectable pancreatic cancer: a retrospective study of 142 patients.

Li J, Chen X, Yang H, Wang X, Yuan D, Zeng Y, Wen T, Yan L, Li B.

Postgrad Med J. 2011 Feb;87(1024):89-95. doi: 10.1136/pgmj.2010.098350. Epub 2010 Dec 3.

PMID:
21131612
4.

Combined biliary and gastric bypass procedures as effective palliation for unresectable malignant disease.

Mann CD, Thomasset SC, Johnson NA, Garcea G, Neal CP, Dennison AR, Berry DP.

ANZ J Surg. 2009 Jun;79(6):471-5. doi: 10.1111/j.1445-2197.2008.04798.x.

PMID:
19566872
5.

Surgical palliation of unresectable periampullary adenocarcinoma in the 1990s.

Sohn TA, Lillemoe KD, Cameron JL, Huang JJ, Pitt HA, Yeo CJ.

J Am Coll Surg. 1999 Jun;188(6):658-66; discussion 666-9.

PMID:
10359359
6.

Complications and survival associated with operative procedures in patients with unresectable pancreatic head adenocarcinoma.

Spanheimer PM, Cyr AR, Liao J, Johlin FC, Hoshi H, Howe JR, Mezhir JJ.

J Surg Oncol. 2014 Jun;109(7):697-701. doi: 10.1002/jso.23560. Epub 2014 Jan 7.

PMID:
24395080
7.

Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer?

Lillemoe KD, Cameron JL, Yeo CJ, Sohn TA, Nakeeb A, Sauter PK, Hruban RH, Abrams RA, Pitt HA.

Ann Surg. 1996 Jun;223(6):718-25; discussion 725-8.

8.

[Surgical palliation for pancreatic cancer. The 25-year experience of a single reference centre].

Popiela T, Kedra B, Sierzega M, Kubisz A.

Zentralbl Chir. 2002 Nov;127(11):965-70. German.

PMID:
12476370
9.

Factors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomas.

Müller MW, Friess H, Köninger J, Martin D, Wente MN, Hinz U, Ceyhan GO, Blaha P, Kleeff J, Büchler MW.

Am J Surg. 2008 Feb;195(2):221-8.

PMID:
18154768
10.

Factors influencing survival in patients undergoing palliative bypass for pancreatic adenocarcinoma.

Gray PJ Jr, Wang J, Pawlik TM, Edil BH, Schulick R, Hruban RH, Dao H, Cameron J, Wolfgang C, Herman JM.

J Surg Oncol. 2012 Jul 1;106(1):66-71. doi: 10.1002/jso.23047. Epub 2012 Feb 3.

11.
12.

Palliation With Endoscopic Metal Stents May Be Preferable to Surgical Intervention for Patients With Obstructive Pancreatic Head Adenocarcinoma.

Kofokotsios A, Papazisis K, Andronikidis I, Ntinas A, Kardassis D, Vrochides D.

Int Surg. 2015 Jun;100(6):1104-10. doi: 10.9738/INTSURG-D-14-00274.1.

13.

Microscopically incomplete resection offers acceptable palliation in pancreatic cancer.

Kuhlmann K, de Castro S, van Heek T, Busch O, van Gulik T, Obertop H, Gouma D.

Surgery. 2006 Feb;139(2):188-96.

PMID:
16455327
14.

[Stent or surgical bypass as palliative therapy in obstructive jaundice].

Wagner M, Egger B, Kulli C, Redaelli CA, Krähenbühl L, Seiler CA, Büchler MW.

Swiss Surg. 2000;6(5):283-8. German.

PMID:
11077497
15.

Biliary stenting versus surgical bypass for palliation of periampullary malignancy.

Nikfarjam M, Hadj AK, Muralidharan V, Tebbutt N, Fink MA, Jones RM, Starkey G, Vaughan RB, Marshall AW, Christophi C.

Indian J Gastroenterol. 2013 Mar;32(2):82-9. doi: 10.1007/s12664-012-0274-1. Epub 2012 Nov 16.

PMID:
23229915
16.

Margin positive pancreaticoduodenectomy is superior to palliative bypass in locally advanced pancreatic ductal adenocarcinoma.

Lavu H, Mascaro AA, Grenda DR, Sauter PK, Leiby BE, Croker SP, Witkiewicz A, Berger AC, Rosato EL, Kennedy EP, Yeo CJ.

J Gastrointest Surg. 2009 Nov;13(11):1937-46; discussion 1946-7. doi: 10.1007/s11605-009-1000-x. Epub 2009 Sep 16.

PMID:
19760308
17.

Prognostic factors in the operative and palliative treatment of pancreatic cancer.

Talar-Wojnarowska R, Gasiorowska A, Strzelczyk J, Janiak A, Malecka-Panas E.

Neoplasma. 2003;50(5):383-7.

PMID:
14628094
18.

Current status of surgical palliation of periampullary carcinoma.

Lillemoe KD, Sauter PK, Pitt HA, Yeo CJ, Cameron JL.

Surg Gynecol Obstet. 1993 Jan;176(1):1-10.

PMID:
7678945
19.

Prognosis following surgical bypass compared with laparotomy alone in unresectable pancreatic adenocarcinoma.

Insulander J, Sanjeevi S, Haghighi M, Ivanics T, Analatos A, Lundell L, Del Chiaro M, Andrén-Sandberg Å, Ansorge C.

Br J Surg. 2016 Aug;103(9):1200-8. doi: 10.1002/bjs.10190. Epub 2016 Jun 2.

PMID:
27250937
20.

Hepaticocholecystojejunostomy as effective palliative biliary bypass for unresectable pancreatic cancer.

Ueda J, Kayashima T, Mori Y, Ohtsuka T, Takahata S, Nakamura M, Tanaka M.

Hepatogastroenterology. 2014 Jan-Feb;61(129):197-202.

PMID:
24895820

Supplemental Content

Support Center